National Institute on Drug Abuse, Notice of Closed Meetings, 1338 [07-76]
Download as PDF
1338
Federal Register / Vol. 72, No. 7 / Thursday, January 11, 2007 / Notices
Dental & Craniofacial Research, National
Institutes of Health, Bethesda, MD 20892,
(301) 594–4827, kims@email.nidr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 07–40, Review R21.
Date: March 6, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm 4AN–32F,
National Institute of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402, 301–594–5006,
lynn.king@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 07–29, Review R21s.
Date: March 9, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm 4AN–32F,
National Institute of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402, 301–594–5006,
lynn.king@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 3, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–73 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on PROD1PC66 with NOTICES
National Institute on Drug Abuse,
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Aug<31>2005
15:52 Jan 10, 2007
Jkt 211001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Centers
Review Committee.
Date: February 19, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401,
301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel Program
Projects.
Date: February 20, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401,
301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group,
Medication Development Research
Subcommittee.
Date: March 5, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott at Metro Center, 775 12th
Street, NW., Washington, DC 20005.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd, Bethesda, MD
20892–8401, 301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Health
Services Research Subcommittee.
Date: March 6–7, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Meenaxi Hiremath, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Blvd., Suite 220, MSC
8401, Bethesda, MD 20892, 301–402–7964,
mh392g@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Treatment
Research Subcommittee.
Date: March 6–7, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Kesinee Nimit, MD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, Md 20892–
8401, (301) 435–1432.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Training
and Career Development Subcommittee.
Date: March 13–15, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MS 8401, Bethesda,
MD 20892–8401, 301–451–4530,
el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 3, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–76 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Technical Support for Constituency Outreach
and Research Dissemination.
Date: February 1, 2007.
Time: 9:30 a.m. to 11:30 p.m.
Agenda: To review and evaluate contract
proposals.
E:\FR\FM\11JAN1.SGM
11JAN1
Agencies
[Federal Register Volume 72, Number 7 (Thursday, January 11, 2007)]
[Notices]
[Page 1338]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-76]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse, Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Centers Review Committee.
Date: February 19, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Rita Liu, PhD, Associate Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, 301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Program Projects.
Date: February 20, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Rita Liu, PhD, Associate Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, 301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Medication Development Research Subcommittee.
Date: March 5, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott at Metro Center, 775 12th Street, NW.,
Washington, DC 20005.
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd,
Bethesda, MD 20892-8401, 301-402-6626, gm145a@nih.gov.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Health Services Research Subcommittee.
Date: March 6-7, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Meenaxi Hiremath, PhD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health, DHHS, 6101 Executive
Blvd., Suite 220, MSC 8401, Bethesda, MD 20892, 301-402-7964,
mh392g@nih.gov.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Treatment Research Subcommittee.
Date: March 6-7, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Kesinee Nimit, MD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard,
Bethesda, Md 20892-8401, (301) 435-1432.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Training and Career Development Subcommittee.
Date: March 13-15, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Bethesda, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Room 220, MS 8401,
Bethesda, MD 20892-8401, 301-451-4530, el6r@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: January 3, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-76 Filed 1-10-07; 8:45 am]
BILLING CODE 4140-01-M